| • |
the audited consolidated financial statements of Neogen as of and for the year ended May 31, 2022, which are included in Neogen’s Annual Report on Form 10-K for the
year ended May 31, 2022, filed with the SEC on July 27, 2022;
|
| • |
the unaudited interim combined financial statements of the Food Safety Business as of June 30, 2022 and for the three and six months ended June 30, 2021 and June 30,
2022, which are included in .2 to 3M’s current report on Form 8-K, filed with the U.S Securities and Exchange Commission on August 12, 2022 (the “interim period Food Safety Business financial statements”); and
|
| • |
the audited combined financial statements of the Food Safety Business as of and for the year ended December 31, 2021 (the “audited annual Food Safety Business financial
statements”), which are included in Neogen’s registration statement on Form S-4 (Registration No. 333-263667), which was declared effective on August 4, 2022 (the “Neogen Registration Statement”).
|
|
Historical
|
Transaction Accounting Adjustments
|
|||||||||||||||||||||||||||
|
Neogen
|
Food Safety
Business after
Reclassification
Adjustments
(Note 3)
|
Pre-Merger
Adjustments
|
Notes
|
Merger
Adjustments
|
Notes
|
Neogen
Pro Forma
Combined
|
||||||||||||||||||||||
|
Assets
|
||||||||||||||||||||||||||||
|
Current assets:
|
||||||||||||||||||||||||||||
|
Cash and cash equivalents
|
$
|
44,473
|
$
|
-
|
$
|
979,188
|
4a
|
|
$
|
(999,963
|
)
|
5, 6a
|
|
$
|
23,698
|
|||||||||||||
|
Marketable securities
|
336,578
|
-
|
-
|
|
-
|
336,578
|
||||||||||||||||||||||
|
Accounts receivable
|
99,674
|
51,686
|
(51,686
|
)
|
4b
|
|
-
|
99,674
|
||||||||||||||||||||
|
Inventories
|
122,313
|
37,703
|
(26,036
|
)
|
4b
|
|
3,014
|
5, 6b
|
|
136,994
|
||||||||||||||||||
|
Prepaid expenses and other current assets
|
23,760
|
5,206
|
(5,206
|
)
|
4b
|
|
-
|
23,760
|
||||||||||||||||||||
|
Total current assets
|
626,798
|
94,595
|
896,260
|
(996,949
|
)
|
620,704
|
||||||||||||||||||||||
|
Property, plant and equipment
|
110,584
|
21,761
|
(2,644
|
)
|
4b
|
|
-
|
129,701
|
||||||||||||||||||||
|
Right-of-use assets
|
3,184
|
1,012
|
-
|
-
|
4,196
|
|||||||||||||||||||||||
|
Goodwill
|
142,704
|
79,983
|
(79,983
|
)
|
4b
|
|
1,190,781
|
5
|
1,333,485
|
|||||||||||||||||||
|
Other intangible assets, net
|
107,503
|
2,934
|
(2,934
|
)
|
4b
|
|
2,600,000
|
5, 6c
|
|
2,707,503
|
||||||||||||||||||
|
Deferred tax assets
|
-
|
6,645
|
(6,645
|
)
|
4b
|
|
-
|
|
- |
|||||||||||||||||||
|
Other non-current assets
|
2,156
|
1,281 |
-
|
-
|
3,437
|
|||||||||||||||||||||||
|
Total assets
|
$
|
992,929
|
$
|
208,211
|
$
|
804,054
|
$
|
2,793,832
|
$
|
4,799,026
|
||||||||||||||||||
|
Historical
|
Transaction Accounting Adjustments
|
|||||||||||||||||||||||||||
|
Neogen
|
Food Safety
Business after
Reclassification
Adjustments
(Note 3)
|
Pre-Merger
Adjustments
|
Notes
|
Merger
Adjustments
|
Notes
|
Neogen
Pro Forma
Combined
|
||||||||||||||||||||||
|
Liabilities and Shareholders’ Equity
|
||||||||||||||||||||||||||||
|
Current liabilities:
|
||||||||||||||||||||||||||||
|
Accounts payable
|
$
|
34,614
|
$
|
12,083
|
(12,083
|
)
|
4b
|
|
$
|
(11,377
|
)
|
5, 6a
|
|
$
|
23,237
|
|||||||||||||
|
Accrued compensation
|
11,123
|
1,609
|
(1,609
|
)
|
4b
|
|
-
|
|
11,123 | |||||||||||||||||||
|
Income tax payable
|
2,126
|
-
|
-
|
-
|
2,126
|
|||||||||||||||||||||||
|
Operating lease liabilities - current
|
-
|
-
|
-
|
-
|
-
|
|||||||||||||||||||||||
|
Other accruals
|
29,981
|
4,217
|
(5,505
|
)
|
4a,b
|
|
(9,157
|
)
|
6e
|
|
19,536
|
|||||||||||||||||
|
Total current liabilities
|
77,844
|
17,909
|
(19,197
|
)
|
(20,534
|
)
|
56,022
|
|||||||||||||||||||||
|
Deferred income taxes
|
17,011
|
8
|
(8
|
)
|
4b
|
|
546,000
|
5, 6d
|
|
563,011
|
||||||||||||||||||
|
Other non-current liabilities
|
10,700
|
708
|
-
|
-
|
11,408
|
|||||||||||||||||||||||
|
Operating lease liabilities – non-current
|
-
|
-
|
-
|
-
|
-
|
|||||||||||||||||||||||
|
Long-term debt
|
-
|
-
|
986,688
|
4a
|
|
-
|
986,688
|
|||||||||||||||||||||
|
Total liabilities
|
105,555
|
18,625
|
967,483
|
525,466
|
1,617,129
|
|||||||||||||||||||||||
|
Shareholders’ equity:
|
||||||||||||||||||||||||||||
|
Common stock
|
17,248
|
-
|
-
|
17,323
|
5, 6e
|
|
34,571
|
|||||||||||||||||||||
|
Parent company net investment
|
- |
237,984
|
(157,504
|
)
|
4b
|
|
(80,480
|
)
|
5, 6e
|
|
-
|
|||||||||||||||||
|
Additional paid-in capital
|
309,984
|
-
|
-
|
2,317,575
|
5, 6e
|
|
2,627,559
|
|||||||||||||||||||||
|
Accumulated other comprehensive income (loss)
|
(27,769
|
)
|
(48,398
|
)
|
-
|
48,398
|
5, 6e
|
|
(27,769
|
)
|
||||||||||||||||||
|
Retained earnings
|
587,911
|
-
|
(5,925
|
)
|
4a
|
|
(34,450
|
)
|
6e
|
|
547,536
|
|||||||||||||||||
|
Total shareholders’ equity
|
887,374
|
189,586
|
(163,429
|
)
|
2,268,366
|
3,181,897
|
||||||||||||||||||||||
|
Total liabilities and shareholders’ equity
|
$
|
992,929
|
$
|
208,211
|
$
|
804,054
|
$
|
2,793,832
|
$
|
4,799,026
|
||||||||||||||||||
|
Historical
|
Transaction Accounting Adjustments
|
|||||||||||||||||||||||||||
|
Neogen
|
Food Safety
Business after
Reclassification
Adjustments
(Note 3)
|
Pre-Merger
Adjustments
|
Notes
|
Merger
Adjustments
|
Notes
|
Neogen
Pro Forma
Combined
|
||||||||||||||||||||||
|
Revenues
|
$
|
527,159
|
$
|
370,403
|
$
|
-
|
$
|
-
|
$
|
897,562
|
||||||||||||||||||
|
Cost of revenues
|
284,146
|
151,673
|
(2,287
|
)
|
4c
|
|
10,589
|
6f
|
|
444,121
|
||||||||||||||||||
|
Gross margin
|
243,013
|
218,730
|
2,287
|
(10,589
|
)
|
453,441
|
||||||||||||||||||||||
|
Operating expenses
|
||||||||||||||||||||||||||||
|
Sales and marketing
|
84,604
|
55,700
|
-
|
-
|
140,304
|
|||||||||||||||||||||||
|
General and administrative
|
82,742
|
29,205
|
(747
|
)
|
4b
|
|
217,227
|
6g
|
|
328,427
|
||||||||||||||||||
|
Research and development
|
17,049
|
25,324
|
-
|
-
|
42,373
|
|||||||||||||||||||||||
|
Total operating expenses (income)
|
184,395
|
110,229
|
(747
|
)
|
217,227
|
511,104
|
||||||||||||||||||||||
|
Operating income (loss)
|
58,618
|
108,501
|
3,034
|
(227,816
|
)
|
(57,663
|
)
|
|||||||||||||||||||||
|
Other income (expense)
|
||||||||||||||||||||||||||||
|
Interest income
|
1,267
|
-
|
-
|
-
|
1,267
|
|||||||||||||||||||||||
|
Finance expense
|
-
|
-
|
-
|
(66,965
|
)
|
6h
|
|
(66,965
|
)
|
|||||||||||||||||||
|
Other income (expense)
|
322
|
-
|
-
|
-
|
322
|
|||||||||||||||||||||||
|
Total other income (expense)
|
1,589
|
-
|
-
|
(66,965
|
)
|
(65,376
|
)
|
|||||||||||||||||||||
|
Income (loss) before taxes
|
60,207
|
108,501
|
3,034
|
(294,781
|
)
|
(123,039
|
)
|
|||||||||||||||||||||
|
Provision for income taxes
|
11,900
|
21,659
|
601
|
6i
|
|
(58,367
|
)
|
6i
|
|
(24,207
|
)
|
|||||||||||||||||
|
Net income (loss)
|
$
|
48,307
|
$
|
86,842
|
$
|
2,433
|
$
|
(236,414
|
)
|
$
|
(98,832
|
)
|
||||||||||||||||
|
Net income (loss) per share available to common stockholders:
|
||||||||||||||||||||||||||||
|
Basic
|
$
|
0.45
|
$
|
(0.46
|
)
|
|||||||||||||||||||||||
|
Diluted
|
$
|
0.45
|
$
|
(0.46
|
)
|
|||||||||||||||||||||||
|
Weighted average shares outstanding:
|
||||||||||||||||||||||||||||
|
Basic
|
107,684
|
215,954
|
||||||||||||||||||||||||||
|
Diluted
|
108,020
|
215,954
|
||||||||||||||||||||||||||
|
Historical Food Safety Business
|
Reclassification Adjustments
|
Notes
|
Historical Food Safety Business after Reclassification Adjustments
|
|||||||||||||
|
Assets
|
||||||||||||||||
|
Current assets:
|
||||||||||||||||
|
Accounts receivable
|
$
|
51,686
|
$
|
-
|
$
|
51,686
|
||||||||||
|
Inventories
|
37,703
|
-
|
37,703
|
|||||||||||||
|
Prepaid expenses and other current assets
|
5,206
|
-
|
5,206
|
|||||||||||||
|
Total current assets
|
94,595
|
-
|
94,595
|
|||||||||||||
|
Property, plant and equipment
|
21,761
|
-
|
21,761
|
|||||||||||||
|
Right-of-use assets
|
1,012
|
-
|
1,012
|
|||||||||||||
|
Goodwill
|
79,983
|
-
|
79,983
|
|||||||||||||
|
Other intangible assets, net
|
2,934
|
-
|
2,934
|
|||||||||||||
|
Deferred tax assets
|
6,645
|
-
|
6,645
|
|||||||||||||
|
Other non-current assets
|
1,281
|
-
|
1,281
|
|||||||||||||
|
Total assets
|
$
|
208,211
|
-
|
$
|
208,211
|
|||||||||||
|
Liabilities and Shareholders’ Equity
|
||||||||||||||||
|
Current liabilities:
|
||||||||||||||||
|
Accounts payable
|
$
|
12,083
|
-
|
$
|
12,083
|
|||||||||||
|
Accrued compensation
|
1,609
|
-
|
1,609
|
|||||||||||||
|
Operating lease liabilities - current
|
287
|
(287
|
)
|
a |
|
-
|
||||||||||
|
Other accruals
|
3,930
|
287
|
a |
|
4,217
|
|||||||||||
|
Total current liabilities
|
17,909
|
-
|
17,909
|
|||||||||||||
|
Deferred income taxes
|
8
|
-
|
8
|
|||||||||||||
|
Other non-current liabilities
|
-
|
708
|
b |
|
708
|
|||||||||||
|
Operating lease liabilities – non-current
|
708
|
(708
|
)
|
b |
|
-
|
||||||||||
|
Long-term debt
|
-
|
|||||||||||||||
|
Total liabilities
|
18,625
|
-
|
18,625
|
|||||||||||||
|
Shareholders’ equity:
|
||||||||||||||||
|
Common stock
|
-
|
-
|
-
|
|||||||||||||
|
Parent company net investment
|
237,984
|
-
|
237,984
|
|||||||||||||
|
Additional paid-in capital
|
-
|
-
|
-
|
|||||||||||||
|
Accumulated other comprehensive income (loss)
|
(48,398
|
) |
- |
(48,398
|
) |
|||||||||||
|
Retained earnings
|
-
|
-
|
-
|
|||||||||||||
|
Total shareholders’ equity
|
189,586
|
-
|
189,586
|
|||||||||||||
|
Total liabilities and shareholders’ equity
|
$
|
208,211
|
-
|
$
|
208,211
|
|||||||||||
|
Historical Food Safety Business
|
Reclassification Adjustments
|
Notes |
Historical Food Safety Business after Reclassification Adjustments
|
|||||||||||||
|
Revenues
|
$
|
-
|
$
|
370,403
|
d |
|
$
|
370,403
|
||||||||
|
Net sales
|
370,403
|
(370,403
|
)
|
d |
|
-
|
||||||||||
|
Cost of revenues
|
-
|
151,673
|
d |
|
151,673
|
|||||||||||
|
Gross margin
|
370,403
|
(151,673
|
)
|
218,730
|
||||||||||||
|
Operating Expenses
|
||||||||||||||||
|
Cost of sales
|
151,673
|
(151,673
|
)
|
d |
|
-
|
||||||||||
|
Sales and marketing
|
-
|
55,700
|
c |
|
55,700
|
|||||||||||
|
General and administrative
|
-
|
29,205
|
c |
|
29,205
|
|||||||||||
|
Selling, general and administrative
|
84,905
|
(84,905
|
)
|
c |
|
-
|
||||||||||
|
Research and development
|
-
|
25,324
|
d |
|
25,324
|
|||||||||||
|
Research, development and related expenses
|
25,324
|
(25,324
|
)
|
d |
|
-
|
||||||||||
|
Total operating expenses (income)
|
261,902
|
(151,673
|
)
|
110,229
|
||||||||||||
|
Income (loss) before taxes
|
108,501
|
-
|
108,501
|
|||||||||||||
|
Provision for income taxes
|
21,659
|
-
|
21,659
|
|||||||||||||
|
Net income (loss)
|
$ |
86,842 | |
-
|
|
$
|
86,842
|
|||||||||
| a) |
Reflects a presentation conforming adjustment to reclassify operating lease liabilities – current, which is presented separately on the face of the Food Safety
Business historical balance sheet to other accruals, as presented on the face of the Neogen historical balance sheet.
|
| b) |
Reflects a presentation conforming adjustment to reclassify operating lease liabilities – non-current, which is presented separately on the face of the Food Safety
Business historical balance sheet to other non-current liabilities, as presented on the face of the Neogen historical balance sheet.
|
| c) |
Reflects a presentation conforming adjustment to reclassify sales and marketing expenses recorded in selling, general and administrative expenses in the Food Safety
Business historical income statements that are presented separately on the face of the Neogen historical income statements.
|
| d) |
Reflects presentation conforming adjustments to reclassify certain line items of the historical Food Safety Business combined statement of income in conformity with
the presentation of Neogen’s historical income statements such as net sales to revenues, cost of sales to cost of revenue and research, development and related expenses to research and development.
|
| a) |
Debt
|
|
As of May 31, 2022
|
|||||
|
Notes
|
350,000
|
||||
|
Term Loan Facility
|
650,000
|
||||
|
Debt issuance costs
|
(13,312
|
)
|
|||
|
Pro forma adjustments to long-term debt
|
986,688
|
||||
| b) |
Reflects a net decrease of $157.5 million to specifically excluded net working capital balances, tax related assets and liabilities, property, plant and equipment and
intangible assets as of May 31, 2022 that will not be transferred to Neogen as part of the Merger as provided in the Separation Agreement and the Asset Purchase Agreement, consisting of $51.7 million of accounts receivable, $26.0 million of
inventories, $5.2 million of prepaid expenses and other current assets, $2.6 million of property, plant and equipment, $80.0 million of goodwill, $2.9 million of other intangible assets, $6.7 million of deferred tax assets – non-current,
$12.1 million of accounts payable, $1.6 million of accrued compensation, $3.9 million of other accruals and $0.01 million in deferred income taxes, with a corresponding decrease to parent company net investment.
|
| c) |
Reflects an adjustment of $2.3 million to cost of revenues for royalties related to products that will continue to be paid by 3M after the Merger.
|
|
Estimated number of shares of Neogen common stock issued and outstanding
|
107,837,730
|
|||
|
Share issuance ratio(i)
|
1.00400802
|
|||
|
Estimated number of shares to be issued to 3M stockholders
|
108,269,946
|
|||
|
Neogen common stock price(ii)
|
$
|
21.56
|
||
|
Estimated fair value of equity shares to be issued
|
$
|
2,334,300
|
||
|
Aggregate consideration to 3M(iii)
|
1,000,000
|
|||
|
Estimated net working capital adjustment
|
(55,021
|
)
|
||
|
Estimated fair value of long-term incentive (“LTI”) replacement awards
|
598
|
|||
|
Estimated total
Merger Consideration(iv)
|
$
|
3,279,877
|
||
|
Recognized amounts of identifiable assets acquired and liabilities assumed
|
||||
|
Net book value of the Food Safety Business historical balance sheet
|
$
|
189,586
|
||
|
Less: Pre-Merger adjustments of net assets acquired as of May 31, 2022
|
(157,504
|
)
|
||
|
Net book value of net assets acquired as of May 31, 2022
|
32,082
|
|||
|
Adjustments to fair value:
|
||||
|
Increase in inventories
|
3,014
|
|||
|
Identifiable intangible assets
|
2,600,000
|
|||
|
Deferred tax liabilities
|
(546,000
|
)
|
||
|
Total Goodwill
|
$
|
1,190,781
|
| i. |
The number of shares of Neogen common stock to be issued is equal to the greater of (x) 108,185,928 or (y) the product of (i) the number of shares of Neogen Common
Stock issued and outstanding immediately prior to the effective time of the Merger multiplied by (ii) 1.00400802.
|
| ii. |
Represents Neogen’s stock price as of August 4, 2022.
|
| iii. |
Represents the sum total of (a) an amount of cash (not to be less than $465 million) determined in accordance with the Separation Agreement, (b) $181.6 million in cash
payable by Neogen to 3M pursuant to the Asset Purchase Agreement plus the amount of cash paid in consideration of any other separately conveyed assets and (c) an aggregate principal amount of Garden SpinCo debt securities equal to $1,000
million (plus or minus any applicable working capital adjustment determined in accordance with the Separation Agreement) minus the amounts paid pursuant to the foregoing clauses (a) and (b).
|
| iv. |
The Merger Consideration will be determined, in part, based on the total number of shares of Neogen common stock that will be issued to former Garden SpinCo
stockholders in the Merger. Because the Exchange Ratio in the Merger Agreement is fixed to result in the number of shares of Neogen common stock that will ultimately be issued in the Merger being equal to the number that will result in former
Garden SpinCo stockholders holding, in the aggregate, 50.1% of the total number of shares of Neogen common stock issued and outstanding immediately following the Merger, the Merger Consideration is not expected to be impacted by whether or
not 3M elects to distribute the Garden SpinCo common stock to 3M stockholders in a pro rata spin-off or an Exchange Offer (including any Clean-Up Spin-Off).
|
| a) |
Cash and cash equivalents
|
| Sources of Funds |
Uses of Funds | |||||||||
|
Term Loan Facility
|
$
|
650,000
|
Merger consideration(i)
|
$
|
(55,021
|
)
|
||||
|
Senior unsecured notes
|
350,000
|
Cash consideration to 3M(ii)
|
1,000,000
|
|||||||
|
Estimated transaction fees and expenses(iii)
|
54,984
|
|||||||||
|
Total sources
|
$
|
1,000,000
|
Total uses
|
$
|
999,963
|
|||||
| i. |
Represents the estimated cash consideration received from 3M as a result of the net working capital payment adjustment as included in the Separation Agreement.
|
| ii. |
Represents aggregate consideration to 3M valued at $1,000.0 million, based on the sum total of (a) an amount of cash (not to be less than $465 million) determined in
accordance with the Separation Agreement, (b) $181.6 million in cash payable by Neogen to 3M pursuant to the Asset Purchase Agreement plus the amount of cash paid in consideration of any other separately conveyed assets and (c) an aggregate
principal amount of Garden SpinCo debt securities equal to $1,000.0 million minus the amounts paid pursuant to the foregoing clauses (a) and (b) minus the net working capital adjustment pursuant to the foregoing clause ii.
|
| iii. |
Represents the estimated fees and expenses associated with the Transactions in the aggregate amount of approximately $55.0 million, including advisory fees and other
transaction costs and professional fees of which $11.4 million has already been recognized as of May 31, 2022 in the historical consolidated financial statements of Neogen.
|
| b) |
Inventories
|
| c) |
Intangible assets
|
| d) |
Deferred tax liabilities
|
| e) |
Total equity
|
| i. |
an increase in equity to reflect the non-cash estimated share consideration issued by
Neogen in the amount of $2,334.3 million of which $17.3 million of equity was issued at par value and $2,317.0 million of equity was issued in excess of par value and $0.6 million of non-cash equity consideration from the fair value of LTI
replacement awards;
|
| ii. |
a decrease in equity to reflect the elimination of the Food Safety Business’ historical
equity of $80.5 million after the adjustment related to the exclusion of $157.5 million in certain assets and liabilities that will not be transferred as part of the Merger;
|
| iii. |
an increase in equity to reflect the elimination of the Food Safety Business’ historical
accumulated other comprehensive income (loss) of $48.4 million; and
|
| iv. |
a decrease in retained earnings of $34.4 million, net of tax, to reflect the additional transaction costs incurred.
|
| f) |
Cost of revenues
|
| g) |
General and administrative
|
| i. |
Amortization of intangible assets
|
|
Estimated
fair value
|
Estimated
useful life
(in years)
|
Amortization
expense for
the year ended May 31, 2022
|
||||||||
|
Finite lived intangible assets
|
||||||||||
|
Trade Names
|
400,000
|
10-20 years
|
26,666
|
|||||||
|
Customer Relationships
|
1,800,000
|
10-20 years
|
120,000
|
|||||||
|
Developed Technology
|
400,000
|
5-25 years
|
26,667
|
|||||||
|
Pro forma adjustment
|
2,600,000
|
173,333
|
||||||||
| ii. |
Transaction fees and expenses
|
| iii. |
Stock based compensation
|
| iv. |
Transition Arrangements
|
| h) |
Finance expense
|
| i) |
Income tax expense
|
|
Year ended
May 31,
2022
|
|||||
|
Pro forma net (loss) attributable to common stockholders
|
(98,832
|
)
|
|||
|
Weighted average number of Neogen shares outstanding – basic
|
107,684
|
||||
|
Neogen shares to be issued to 3M stockholders as part of purchase consideration
|
108,270
|
||||
|
Pro forma weighted average number shares outstanding — basic and diluted
|
215,954
|
||||
|
Pro forma net (loss) per share of common stock — basic and diluted
|
$
|
(0.46
|
)
|
||